(R)-2-Benzyl-5-ethyl-7-propyl-7,8-dihydro-1H,5H-imidazo[2,1-b]purin-4-one

ID: ALA364459

Chembl Id: CHEMBL364459

PubChem CID: 44401904

Max Phase: Preclinical

Molecular Formula: C19H23N5O

Molecular Weight: 337.43

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCC[C@@H]1CN2C(=N1)N(CC)C(=O)c1[nH]c(Cc3ccccc3)nc12

Standard InChI:  InChI=1S/C19H23N5O/c1-3-8-14-12-24-17-16(18(25)23(4-2)19(24)20-14)21-15(22-17)11-13-9-6-5-7-10-13/h5-7,9-10,14H,3-4,8,11-12H2,1-2H3,(H,21,22)/t14-/m1/s1

Standard InChI Key:  LTGJJULPHZEBHN-CQSZACIVSA-N

Alternative Forms

1. Parent:

   

   ALA364459

   (R)-2-Benzyl-5-ethyl-7-propyl-7,8-dihydro-1H,5H-imidazo[2,1-b]purin-4-one

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 337.43

Molecular Weight (Monoisotopic): 337.1903

AlogP: 2.82

#Rotatable Bonds: 5

Polar Surface Area: 64.59

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.95

CX Basic pKa: 3.28

CX LogP: 3.30

CX LogD: 3.30

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.91

Np Likeness Score: -0.49

References

1. Boyle CD, Xu R, Asberom T, Chackalamannil S, Clader JW, Greenlee WJ, Guzik H, Hu Y, Hu Z, Lankin CM, Pissarnitski DA, Stamford AW, Wang Y, Skell J, Kurowski S, Vemulapalli S, Palamanda J, Chintala M, Wu P, Myers J, Wang P..  (2005)  Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED.,  15  (9): [PMID:15837326] [10.1016/j.bmcl.2005.02.083]

Source

Source(1):

• Scientific Literature